Simple Summary Uveal melanoma (UM) is a rare aggressive eye cancer. Although
treatment of the eye tumour is successful, about 50% of UM patients develop a relapse of …

Background Uveal melanoma (UM) represents the most common primary intra-ocular
malignancy in adults. Up to 50% of the patients develop distant metastases within 10 years …

Background Uveal melanoma (UM) is the most common primary intraocular malignancy with
a strong tendency to metastasize. The prognosis is poor once metastasis occurs. The …

Background To date, no systemic therapy, including immunotherapy, exists to improve
clinical outcomes in metastatic uveal melanoma (UM) patients. To understand the role of …

Purpose Uveal melanoma (UM) is adults' most common primary intraocular malignant tumor.
It has been observed that 40% of patients experience distant metastasis during subsequent …

Tumor‐infiltrating immune cells are capable of effective cancer surveillance, and their
abundance is linked to better prognosis in numerous tumor types. However, in uveal …

purpose. The liver is the most common site of systemic metastases from uveal melanoma
(UM). Such metastases usually continue to develop despite the application of current …

Background: Uveal melanoma (UM) is the most frequent ocular neoplasm with a strong
metastatic ability. The prognostic value of metastasis-associated genes (MAGs) of UM …

Uveal melanoma is an aggressive intraocular malignancy that often exhibits low
immunogenicity. Metastatic uveal melanoma samples frequently exhibit monosomy 3 or …

Simple Summary This study pursued the proteomic analysis of primary uveal melanoma
(pUM) for insights into the mechanisms of metastasis and protein biomarkers. Liquid …